Skip to content
OpenCapital
Get started

Vera Therapeutics VERA Increase (Decrease) in Other Current Assets

Increase (Decrease) in Other Current Assets at other companies

TG Therapeutics logo
TG TherapeuticsTGTX
——

Other financials

Income statement

See full
Operating income-$125.1M-119%
Net income-$121.0M-134%
EPS (diluted)-$1.69-109%

Balance sheet

See full
Cash & equivalents$114.4M+108%
Total debt$75.0M+37.8%
Total equity$499.7M-6.6%
Total assets$621.7M+1.9%

Cash flow

See full
Operating cash flow-$106.5M-95.8%
CapEx$23.0K-87.7%
Free cash flow-$106.5M-95.1%

Valuation

See full
Market cap$2.84B+87.5%

Returns & leverage

See full
Return on equity-71.3%+296pp
Debt / equity0.2×0.0×
Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentAssets.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's increase (decrease) in other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vera Therapeutics's increase (decrease) in other current assets?
Vera Therapeutics (VERA) reported increase (decrease) in other current assets of $0 in Q1 2026.
How has Vera Therapeutics's increase (decrease) in other current assets changed year-over-year?
Vera Therapeutics's increase (decrease) in other current assets increased by 100.0% year-over-year, from -$17K to $0.
What is the long-term trend for Vera Therapeutics's increase (decrease) in other current assets?
Over 2 years (2021 to 2024), Vera Therapeutics's increase (decrease) in other current assets has grown at a 162.3% compound annual growth rate (CAGR), from $51K to -$351K.